CS
SWAV

Credit Suisse’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Credit Suisse’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$77.3M Sell
237,491
-166,328
-41% -$40.8M 0.07% 264
2023
Q4 		$77M Buy
403,819
+40,211
+11% +$7.6M 0.07% 264
2023
Q3 		$72.4M Buy
363,608
+56,298
+18% +$13.3M 0.07% 274
2023
Q2 		$87.7M Sell
307,310
-67,228
-18% -$18.7M 0.09% 235
2023
Q1 		$81.2M Buy
374,538
+123,383
+49% +$24M 0.08% 243
2022
Q4 		$51.6M Sell
251,155
-18,322
-7% -$4.63M 0.05% 383
2022
Q3 		$74.9M Sell
269,477
-226,203
-46% -$57.5M 0.08% 251
2022
Q2 		$94.8M Sell
495,680
-179,614
-27% -$31.7M 0.1% 215
2022
Q1 		$140M Sell
675,294
-14,365
-2% -$2.37M 0.12% 171
2021
Q4 		$123M Buy
689,659
+88,622
+15% +$17.5M 0.07% 311
2021
Q3 		$124M Sell
601,037
-201,990
-25% -$39.7M 0.07% 294
2021
Q2 		$152M Sell
803,027
-89,352
-10% -$14.6M 0.08% 258
2021
Q1 		$116M Buy
892,379
+863,176
+2,956% +$104M 0.06% 355
2020
Q4 		$3.03M Buy
29,203
+12,638
+76% +$1.09M ﹤0.01% 2514
2020
Q3 		$1.25M Sell
16,565
-19,306
-54% -$1.09M ﹤0.01% 2764
2020
Q2 		$1.7M Buy
35,871
+28,284
+373% +$1.17M ﹤0.01% 2511
2020
Q1 		$251K Buy
7,587
+1,966
+35% +$78.1K ﹤0.01% 3530
2019
Q4 		$247K Buy
+5,621
New +$208K ﹤0.01% 3909

Other funds holding SWAV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credit Suisse's SWAV Position: Q1 2024 in Review

Credit Suisse reduced its Shockwave Medical, Inc. Common Stock (SWAV) stake by 41% in Q1 2024, selling an estimated $40.8M and leaving 237,491 shares worth $77.3M. The position accounts for 0.07% of the portfolio, ranked #264.

Credit Suisse first reported a position in SWAV in Q4 2019 and has held it in 18 quarters since. The position peaked at $152M in Q2 2021. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • Credit Suisse held 237,491 shares of Shockwave Medical, Inc. Common Stock worth $77.3M as of Q1 2024.
  • Credit Suisse sold 166,328 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $40.8M.
  • Shockwave Medical, Inc. Common Stock made up 0.07% of Credit Suisse's portfolio in Q1 2024, its #264 holding.
  • Credit Suisse first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2019 and has held it in 18 quarters since.
  • Credit Suisse's Shockwave Medical, Inc. Common Stock position peaked at $152M in Q2 2021.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.